Grants and Contributions:
Title:
Engineered yeast strains for secretion of antibacterial agents in biofuel ferments
Agreement Number:
907349
Agreement Value:
$75,000.00
Agreement Date:
May 1, 2018 - Aug 31, 2019
Description:
Bacterial contamination in commercial ethanol fermentations can decrease ethanol yield and negatively impact the economics of ethanol production. Currently, antibiotics are used to prevent bacterial infections in ethanol fermentations, which is costly and can lead to the emergence of antibiotic-resistant bacteria. Our goal is to develop a method for producing an antibacterial yeast strain that can be used in ethanol fermentations without the addition of antibiotics.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6E 3P3
Reference Number:
172-2018-2019-Q1-907349
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
828790972
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 2 time(s). The end date of this agreements has been modified by 169 days.
Amendment Date
Feb 19, 2019
Recipient's Legal Name:
Creatus Biosciences Inc.
Federal Riding Name:
Vancouver South
Federal Riding Number:
59040
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: